Lückmann Sara Lena, Förster Antonia, Heinrich Stephanie, Buhtz Christian, Meyer Gabriele, Mikolajczyk Rafael, Fleischer Steffen
Institute for Medical Epidemiology, Biometrics and Informatics, Magdeburger Str. 8 06112, Halle (Saale), Germany.
Institute for Health and Nursing Science, Magdeburger Str. 8, 06112, Halle (Saale), Germany.
Diabetes Res Clin Pract. 2024 Dec;218:111935. doi: 10.1016/j.diabres.2024.111935. Epub 2024 Nov 22.
Continuous glucose measurement (CGM) systems are increasingly utilised by people with diabetes mellitus (DM) and less is known about usage behaviour. Therefore, this study aims to analyse additionally utilisation of blood glucose measurement (BGM) for insurants who are using CGM.
The study used secondary data, health claims data from the AOK Saxony-Anhalt (Germany), from 2016 to 2021, analysing a sample of 52,296 individuals with insulin-requiring DM.
Nearly all CGM users reduced their utilisation of BGM test strips. 2,306 persons with CGM long-time utilisation, about half showed a mean usage behaviour, nearly one third did not use test strips anymore, about 8 % stopped using CGM, 9 % were intense users. A high test strip utilisation beside CGM was associated with younger age, T1DM, a high number of test strip before starting CGM, no contact with a general practitioner, and no enrolment in a disease management program.
Great differences in reductions and usage behaviour was revealed between insurants. The results can be used to better identify and offer more tailored CGM to people with DM, and to better tailor CGM trainings.
糖尿病患者越来越多地使用持续葡萄糖监测（CGM）系统，而对其使用行为的了解较少。因此，本研究旨在分析使用CGM的被保险人额外使用血糖测量（BGM）的情况。
本研究使用了二手数据，即2016年至2021年德国萨克森-安哈尔特州AOK的健康索赔数据，分析了52296名需要胰岛素治疗的糖尿病患者样本。
几乎所有CGM用户都减少了BGM试纸的使用。2306名长期使用CGM的患者中，约一半表现出平均使用行为，近三分之一不再使用试纸，约8%停止使用CGM，9%是频繁使用者。CGM之外较高的试纸使用率与年龄较小、1型糖尿病、开始使用CGM之前较高的试纸使用量、未与全科医生接触以及未参加疾病管理项目有关。
被保险人在减少使用和使用行为方面存在很大差异。这些结果可用于更好地识别糖尿病患者并为其提供更具针对性的CGM，并更好地定制CGM培训。
